Navigation Links
CoreSpine Technologies(TM) Receives Clearance to Market Surgical Disc Preparation Device
Date:5/4/2009

Company Achieves Major Milestone with Limited Start-up Funding

MINNEAPOLIS, May 4 /PRNewswire/ -- CoreSpine Technologies, a Minneapolis-based spinal device developer, announced today it has received 510(k) clearance to market from the U.S. Food and Drug Administration (FDA) for its XTEND-ST(TM) Nucleus Removal System.

"The clearance of the XTEND-ST device is truly a significant achievement for CoreSpine," said Christine Horton, Chief Executive Officer of CoreSpine Technologies. "The XTEND-ST is a safe and effective device for removing lumbar disc material and satisfies a large unmet need within the spine industry. Of equal significance is that CoreSpine was able to develop the product with minimal funding over the past three years. I credit the many dedicated and talented medical device professionals that work with CoreSpine and the company's ability to operate lean yet with a defined purpose."

"The need for CoreSpine's technology increases as additional spinal implants and new approaches are introduced to spine surgeons," said John Sherman, M.D., spine surgeon with Twin Cities Orthopedics in Minneapolis, Minnesota. Dr. Sherman continued, "I continue to be impressed with the company's history of developing new technology with limited funds."

About CoreSpine Technologies, LLC

CoreSpine Technologies, LLC is a privately held spinal device manufacturer headquartered in Minneapolis, Minnesota. The company's focus is on expanding its platform technology to produce advanced surgical devices for the complete or selective removal of material from the lumbar disc space. The first products will initially set the standard for preparing the spinal disc for minimally invasive fusion with applications in a variety of emerging spinal therapies. For additional information, please visit the company's website at www.corespinetech.com.


'/>"/>
SOURCE CoreSpine Technologies, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Baxa Corporation Acquires Florida-Based ForHealth Technologies(TM)
2. Insurance Defense Law Firm Receives Recognition from Martindale-Hubbell
3. BMP Sunstone Receives Nasdaq Compliance Notice
4. BMP Sunstone Compliance Receives Nasdaq Notice
5. Stratfords Institutional Investment Consulting Service Receives HFMA Peer Review Designation
6. Excelsior Medical Corporation Receives FDA Approval to Market SwabCap(TM) Luer Access Valve Disinfection Cap
7. Solta Medical Receives Regulatory Approval to Market Thermage Systems in China
8. IMRIS receives CE Mark approval for interventional imaging system
9. Insulet Receives CE Mark for the OmniPod(R) Insulin Management System
10. Houston Northwest Medical Center Receives Prestigious Tenet Circle of Excellence Award
11. SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology: